The following research projects were approved by Susan G. Komen's national Board of Directors for funding, and will be funded once the Grant Agreements between Komen and the Grantee institution(s) are fully-executed. There are 7 types (mechanisms) of grants: Career Catalyst Research (CCR), Graduate Training in Disparities Research (GTDR), Postdoctoral Fellowships (PDF), Komen Scholars Grants (KS), Scientific Advisory Board Grants (SAB), Opportunity Grants (OG), and Sponsored Programs and Partnerships (SPP). For more information on the scientific programs and partnerships that are supported by the Komen Research Program, see here.

Select a column title to sort this information.
Select a Project Title for detailed grant information.
Download Printable Version

Type to Search:
Project Title Investigators Organization State/ Country Affiliate Mechanism
Obesity-Activated Macrophages Promote Tumorigenesis Lisa Arendt, D.V.M., Ph.D. University of Wisconsin - Madison WI South Central Wisconsin Affiliate CCR Basic and Translational
Targeting the stem cell niche in aggressive breast cancers  Jay Desgrosellier, Ph.D. University of California, San Diego  CA San Diego Affiliate CCR Basic and Translational
Novel therapeutic approach to triple-negative breast cancer: role of antioxidants  Chiara Gorrini, Ph.D. University Health Network - Toronto Canada

 

CCR Basic and Translational
Causal Changes in DNA Methylation and Breast Cancer Development  Chunyan He, Sc.D. Indiana University (Indianapolis) IN Central Indiana Affiliate CCR Basic and Translational
The role of RAGE-ligand signaling in breast cancer progression and metastasis  Barry Hudson, Ph.D. Miller School of Medicine of the University of Miami  FL Miami/Ft. Lauderdale Affiliate CCR Basic and Translational
Novel microRNA pathways regulating breast cancer stem cells and metastasis  Huiping Liu, M.D., Ph.D. Case Western Reserve University OH Northeast Ohio Affiliate CCR Basic and Translational
Mechanisms of normal-to-malignant transformation in the breast.  Luke McCaffrey, Ph.D. McGill University Canada

 

CCR Basic and Translational
Estrogen receptor reactivation for treatment of advanced breast cancer  Todd Miller, Ph.D. Dartmouth College  NH Vermont-New Hampshire Affiliate CCR Basic and Translational
Disruption of the tumor microenvironment in Her2+ breast to brain metastases  Josh Neman, Ph.D. USC/University of Southern California  CA Los Angeles County Affiliate CCR Basic and Translational
Targeting serine and glycine metabolism in breast cancer Richard Possemato, Ph.D. New York University School of Medicine NY Greater New York City Affiliate CCR Basic and Translational
Delineation and mutational analysis of open chromatin regions in breast cancer  Trevor Pugh, Ph.D. University Health Network - Toronto Canada

 

CCR Basic and Translational
Dual immunotherapy plus a HER2 vaccine reverses anergy to eliminate breast cancer    William Redmond, Ph.D. Providence Portland Medical Center  OR Oregon and SW Washington Affiliate CCR Basic and Translational
Targeting PI3K and CDK4/6 in breast cancer: integrative biomarkers of response  Violeta Serra, Ph.D. Vall d'Hebron Institute of Oncology  Spain

 

CCR Basic and Translational
Improving MUC1-targeted immunotherapy to eliminate established breast cancer  Adam Soloff, Ph.D. Medical University of South Carolina  SC Lowcountry Affiliate CCR Basic and Translational
Fibulin-3 as a novel biomarker and target in the breast tumor microenvironment Hongyu Tian, Ph.D. Duke University Medical Center NC North Carolina Triangle to the Coast Affiliate CCR Basic and Translational
Breast cancer immunotherapy targeting sentinel lymph nodes  Susan Thomas, Ph.D. Georgia Tech Research Corporation  GA Greater Atlanta Affiliate CCR Basic and Translational
Receptor activator of nuclear factor-kB (RANK)-axis and mammographic density  Adetunji Toriola, M.D., Ph.D. Washington University School of Medicine  MO St. Louis Affiliate CCR Basic and Translational
Dissecting IRES mediated translation in breast cancer  Christos Vaklavas, M.D. University of Alabama at Birmingham  AL North Central Alabama Affiliate CCR Basic and Translational
Diagnostic and therapeutic implications of extracellular HMGA1 in breast cancer Josep Villanueva, Ph.D. Vall d'Hebron Institute of Oncology  Spain

 

CCR Basic and Translational
Identifying resistance mechanisms in ER+ breast cancer by translational genomics  Nikhil Wagle, M.D. Dana-Farber Cancer Institute  MA Massachusetts Affiliate CCR Basic and Translational
Control of mitochondrial function by EglN2 in breast cancer  Qing Zhang, Ph.D. University of North Carolina at Chapel Hill  NC North Carolina Triangle to the Coast Affiliate CCR Basic and Translational
Genomic and functional circulating tumor cell analysis for personalized therapy Aditya Bardia, MBBS, MPH Massachusetts General Hospital MA Massachusetts Affiliate CCR Clinical
Nail salon work and mammographic density in Vietnamese Americans  Eunjung Lee, Ph.D. USC/University of Southern California  CA Los Angeles County Affiliate CCR Clinical
Molecular, treatment and behavioral factors in breast cancer race disparities  Katherine Reeder-Hayes, M.D. University of North Carolina at Chapel Hill  NC North Carolina Triangle to the Coast Affiliate CCR Clinical
Graduate Training in Breast Cancer Disparities at Lombardi Cancer Center  Lucile Adams-Campbell, Ph.D. Georgetown University  Washington, DC

 

Graduate Training in Disparities Research Grants
Boston University Mentoring and Training in Cancer Health Disparities (MATCH)  Tracy Battaglia, M.D. Boston University, B U Medical Campus  MA Massachusetts Affiliate Graduate Training in Disparities Research Grants
Continuing an American Indian Breast Cancer Disparities Training Program  Christine Daley, Ph.D. University of Kansas Medical Center Research Institute KS Greater Kansas City Affiliate Graduate Training in Disparities Research Grants
Tufts Breast Cancer Training Program to Reduce Asian Health Disparities  Karen Freund, M.D.; Susan Parsons, M.D. Tufts Medical Center  MA Massachusetts Affiliate Graduate Training in Disparities Research Grants
Training Program in Breast Cancer Survivorship Disparities Research  Karen Meneses, Ph.D.; Wendy Demark-Wahnefried, Ph.D., R.D. University of Alabama at Birmingham  AL North Central Alabama Affiliate Graduate Training in Disparities Research Grants
The Ohio State University Breast Cancer Disparities Research Training Program  Electra Paskett, Ph.D. Ohio State University  OH Columbus Affiliate Graduate Training in Disparities Research Grants
Using Hsp90 inhibitors to treat triple negative breast cancer  Abena Agyeman, Ph.D.; Suzanne Conzen, M.D. (Mentor); Rita Nanda, M.D. (Co-Mentor) University of Chicago  IL Chicagoland Area Affiliate PDF Basic and Translational
Loss of the lncRNA Malat1 impacts breast tumor progression and metastasis  Gayatri Arun, Ph.D.; David Spector, Ph.D. (Mentor) Cold Spring Harbor Laboratory NY Greater New York City Affiliate PDF Basic and Translational
Ubiquitin-dependent regulation of EMT in breast cancer metastasis  Antoni Celia-Terrassa, Ph.D.; Yibin Kang, Ph.D. (Mentor) Princeton University  NJ Central and South Jersey Affiliate PDF Basic and Translational
A novel function for ALK4 in suppressing breast cancer progression  Jian Chen, Ph.D.; Gerard Blobe, M.D., Ph.D. (Mentor); Donald McDonnell, Ph.D. (Co-Mentor) Duke University Medical Center NC North Carolina Triangle to the Coast Affiliate PDF Basic and Translational
Clinical identification and regulation of cancer stem cells in TNBC  Yuanzhang Fang, Ph.D.; Yi Li, Ph.D. (Mentor); Michael Lewis, Ph.D. (Co-Mentor) Baylor College of Medicine  TX Houston Affiliate PDF Basic and Translational
Overcoming resistance to treatment of brain metastases from HER2 positive breast  Gino Ferraro, Ph.D.; Rakesh Jain, Ph.D. (Mentor) Massachusetts General Hospital MA Massachusetts Affiliate PDF Basic and Translational
Cellular and molecular mechanisms of breast cancer invasion  Dan Hossamov Georgess, Ph.D.; Andrew Ewald, Ph.D. (Mentor) Johns Hopkins University-School of Medicine  MD Maryland Affiliate PDF Basic and Translational
Dynamics of cell fate decisions after breast cancer radiotherapy  Adrian Granada, Ph.D.; Galit Lahav, Ph.D. (Mentor); Joan Brugge, Ph.D. (Co-Mentor) Harvard Medical School  MA Massachusetts Affiliate PDF Basic and Translational
Hippo pathway activation in chemo-sensitive and -insensitive breast cancer  Sara Hanna, Ph.D.; Gary Johnson, Ph.D. (Mentor) University of North Carolina at Chapel Hill NC North Carolina Triangle to the Coast Affiliate PDF Basic and Translational
Targeting urokinase receptor for diagnosis & therapy of aggressive breast cancers  Efrat Harel, Ph.D.; Charles Craik, Ph.D. (Mentor); Laura van't Veer, Ph.D. (Co-Mentor) University of California, San Francisco CA San Francisco Bay Area Affiliate PDF Basic and Translational
A role for PDK1 in acquired resistance to CDK4/6 inhibitors Valerie Jansen, M.D., Ph.D.; Carlos Arteaga, M.D. (Mentor) Vanderbilt University Medical Center  TN Greater Nashville Affiliate PDF Basic and Translational
Targeting basal-like breast cancer via CRISPR-mediated multiplex gene knockout  Xin Jin, Ph.D.; Todd Golub, M.D. (Mentor); Kwanghun Chung, Ph.D. (Co-Mentor) Broad Institute MA Massachusetts Affiliate PDF Basic and Translational
Radiation-Enhanced Immunotherapy for Recurrent and Metastatic Breast Cancer  Steve Lee, Ph.D.; Stephen Kron, M.D., Ph.D. (Mentor); Ralph Weichselbaum, M.D. (Co-Mentor) The University of Chicago IL Chicagoland Area Affiliate PDF Basic and Translational
Targeting CDK8 to overcome resistance to targeted therapies in breast cancer  Martina McDermott, Ph.D.; Igor Roninson, Ph.D. (Mentor) University of South Carolina - USC  SC SC Mountains to Midlands Affiliate PDF Basic and Translational
The role of breast cancer exosomes in organotropic metastasis  Ayuko Nitadori, Ph.D.; David Lyden, M.D., Ph.D. (Mentor); Jacqueline Bromberg, M.D., Ph.D. (Co-Mentor) Joan & Sanford I. Weill Medical College of Cornell University  NY Greater New York City Affiliate PDF Basic and Translational
The consequences of centrosome amplification in breast cancer  Remigio Picone, Ph.D.; David Pellman, M.D. (Mentor); Kornelia Polyak, M.D., Ph.D. (Co-Mentor) Dana-Farber Cancer Institute  MA Massachusetts Affiliate PDF Basic and Translational
ß1-integrin hyperactivation as a novel anti-breast cancer therapy Laila Ritsma, Ph.D.; Sridha Ramaswamy, M.D. (Mentor) Massachusetts General Hospital MA Massachusetts Affiliate PDF Basic and Translational
Therapy of triple negative breast cancers by targeting the TPX2 mitotic regulator  Julia Rohrberg, Ph.D.; Andrei Goga, M.D., Ph.D. (Mentor); Zena Werb, Ph.D. (Co-Mentor) University of California, San Francisco CA San Francisco Bay Area Affiliate PDF Basic and Translational
Chromosomal enhancer/architectural misregulation in breast cancer  Jia Shen, Ph.D.; Michael Rosenfeld, M.D. (Mentor) University of California, San Diego  CA San Diego Affiliate PDF Basic and Translational
Targeting breast to bone metastases via bone seeking metalloproteinase inhibitors  Marilena Tauro, Ph.D.; Conor Lynch, Ph.D. (Mentor); Srikumar Chellappan, Ph.D. (Co-Mentor) H. Lee Moffitt Cancer Center & Research Institute  FL Florida Suncoast Affiliate PDF Basic and Translational
Characterizing the anti-tumorigenicity, structure, and biochemistry of proBMPs  Yuan Tian, Ph.D.; Timothy Springer, Ph.D. (Mentor); Judy Lieberman, Ph.D. (Co-Mentor) Children's Hospital Boston  MA Massachusetts Affiliate PDF Basic and Translational
NLK inhibitor as new targeted agent for endocrine resistant breast cancers  Xian Wang, Ph.D.; Xiaosong Wang, M.D., Ph.D. (Mentor); Rachel Schiff, Ph.D. (Co-Mentor) Baylor College of Medicine  TX Houston Affiliate PDF Basic and Translational
Epigenetic coding of EMT regulators as diagnostic targets for breast cancer  Yun Zhang, Ph.D; Robert Weinberg, Ph.D. (Mentor) Whitehead Institute for Biomedical Research  MA Massachusetts Affiliate PDF Basic and Translational
PARP inhibition in homologous recombination-deficient breast cancer  Anosheh Afghahi, M.D.; James Ford, M.D. (Mentor); Melinda Telli, M.D. (Co-Mentor) Stanford University  CA San Francisco Bay Area Affiliate PDF Clinical
Uncovering mechanisms responsible for shoulder morbidity following radiotherapy  David Lipps, Ph.D.; Jonathan Strauss, M.D. (Mentor); Eric Perreault, Ph.D. (Co-Mentor) Northwestern University IL Chicagoland Area Affiliate PDF Clinical
Disseminating BHGI guidelines in a Knowledge Summary format among policy stakeholders in Peru, a Middle-Income Country Benjamin Anderson, M.D. Fred Hutchinson Cancer Research Center WA Puget Sound Affiliate Komen Scholars
Examining the Role of Cholesterol Metabolites on the Estrogen Receptor Signaling Pathway Kimberly Blackwell, M.D. Duke University NC North Carolina Triangle to Coast Affiliate Komen Scholars
Biomechanical profiling as a biomarker for breast cancer progression Gerard Blobe, M.D., Ph.D. Duke University NC North Carolina Triangle to Coast Affiliate Komen Scholars
Analysis of the Integration of Cell-Cell Adhesion & Yap Networks Regulating Tumor Growth & Invasion Joan Brugge, Ph.D. Harvard Medical School MA Massachusetts Affiliate Komen Scholars
Hereditary breast cancer: cause and effect William Foulkes, M.D., Ph.D. McGill University Canada NA Komen Scholars
Stress reduction in breast cancer survivors: intervention development and evaluation Patricia Ganz, M.D. University of California, Los Angeles CA Los Angeles County Affiliate Komen Scholars
Toxicities of Breast Cancer Treatment Sharon Giordano, M.D. MD Anderson TX Houston Affiliate Komen Scholars
Muscle Weakness Associated with Breast Cancer Bone Metastases Theresa Guise, M.D. Indiana University IN Central Indiana Affiliate Komen Scholars
Using breast tissue expression patterns to inform our understanding of breast cancer risk factors Susan Hankinson, Sc.D. Brigham and Women's Hospital and Harvard Medical School MA Massachusetts Affiliate Komen Scholars
Novel Devices to Capture Circulating Tumor Cells Daniel Hayes, M.D. University of Michigan MI Mid-Michigan Affiliate Komen Scholars
MR imaging phenotypes of breast cancer Nola Hylton, Ph.D. University of California, San Francisco CA San Francisco Bay Affiliate Komen Scholars
Uncovering mechanisms contributing to metastasis and to drug resistance in breast cancer Nancy Hynes, Ph.D. Friedrich Miescher Institute for Biomedical Research Switzerland

 

Komen Scholars
Mechanisms of Endocrine Action: ER-Induced Apoptosis and HRT-associated breast cancer V. Craig Jordan, Ph.D. UT M.D. Anderson Cancer Center TX Houston Affiliate Komen Scholars
Molecular and clinical characterization of breast cancer heterogeneity in Israel Bella Kaufman, M.D. Chaim Sheba Medical Center Israel

 

Komen Scholars
Identification of new genes for inherited breast cancer by application of next generation sequencing in high-risk families Mary-Claire King, Ph.D. University of Washington WA Puget Sound Affiliate Komen Scholars
Mechanism by which BRCA1 elicits a state of mammary epithelial differentiation control David Livingston, M.D. Dana-Farber Cancer Institute and Harvard Medical School MA Massachusetts Affiliate Komen Scholars
Combinatorial adaptive resistance therapy in breast cancer Gordon Mills, M.D., Ph.D. UT M.D. Anderson Cancer Center TX Houston Affiliate Komen Scholars
Translating Breast Cancer Genomics In The Clinic Olufunmilayo Olopade, M.D. University of Chicago IL Chicagoland Area Affiliate Komen Scholars
Interplay between SRC-3, TRAF4 and ERK3 in breast cancers Bert O'Malley, M.D. Baylor College of Medicine TX Houston Affiliate Komen Scholars
Breast cancer in young women Ann Partridge, M.D. Dana-Farber Cancer Institute MA Massachusetts Affiliate Komen Scholars
Breast cancer cell sensitivity to radiotherapy in the presence of PARP inhibitors Lori Pierce, M.D. University of Michigan MI Mid-Michigan Affiliate Komen Scholars
Triple negative breast cancer: subtypes, molecular targets, and therapeutic approaches Jennifer Pietenpol, Ph.D. Vanderbilt University TN Greater Nashville Affiliate Komen Scholars
Plk2 function in mammary gland development and breast cancer Jeffrey Rosen, Ph.D. Baylor College of Medicine TX Houston Affiliate Komen Scholars
Overcoming or preventing resistance to HER2 targeted therapies Neil Spector, M.D. Duke University School of Medicine NC North Carolina Triangle to Coast Affiliate Komen Scholars
Phase II study of 5-azacytidine and entinostat (MS-275) in patients with advanced breast cancer Vered Stearns, M.D. Sidney Kimmel Cancer Center at Johns Hopkins University School of Medicine MD

 

Komen Scholars
Validation and implementation of genomic testing for chemotherapy and endocrine sensitivity W. Fraser Symmans, M.D. UT M.D. Anderson Cancer Center TX Houston Affiliate Komen Scholars
Optimizing Therapy for Early-Stage Triple-Negative Breast Cancer Melinda Telli, M.D. Stanford University CA San Francisco Bay Area Affiliate Komen Scholars
Mammary stem cells and breast cancer Geoffrey Wahl, Ph.D. The Salk Institute for Biological Studies CA San Diego Affiliate Komen Scholars
MRI Guided preoperative partial breast irradiation in early stage breast cancer Julia White, M.D. Ohio State University OH Columbus Komen Scholars
Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center Anna Maria Storniolo, M.D. Indiana University IN Central Indiana Affiliate Opportunity Grants
Translational Breast Cancer Research Consortium Antonio Wolff, M.D. Johns Hopkins University MD Maryland Affiliate Opportunity Grants
Biospecimen Bank for Determinants of Late Relapse in Operable Breast Cancer Joseph Sparano, M.D. ECOG Research and Education Foundation PA Philadelphia Affiliate Opportunity Grants
Carolina Breast Cancer Study 3 Shelley Earp, M.D. University of North Carolina NC North Carolina Triangle to the Coast Affiliate Opportunity Grants
Implementing breast cancer care efficiency in Zambia through specialized health provider training and health evaluation of patient outcomes Groesbeck Parham, M.D. University of North Carolina NC North Carolina Triangle to the Coast Affiliate Opportunity Grants
Elucidating ER Transcriptional Network Associated With Endocrine Resistance Myles Brown, M.D. Dana-Farber Cancer Institute MA Massachusetts Affiliate SAB  Grants
Identification of phosphatases for the treatment of ER-negative breast cancer Powel Brown, M.D., Ph.D. UT M.D. Anderson Cancer Center TX Houston Affiliate SAB  Grants
Rx for Better Breast Health Amelie Ramirez, Dr. PH UT Health Science Center at San Antonio TX San Antonio Affiliate SAB  Grants
Measuring Circulating Tumor Cells in vivo for Breast Cancer Metastasis Detection George Sledge, Jr., M.D. Stanford University CA San Francisco Bay Area Affiliate SAB  Grants
Improving Treatment Approaches For Women With HER2+ Metastatic Breast Cancer Eric Winer, M.D. Dana-Farber Cancer Institute MA Massachusetts Affiliate SAB  Grants
Brinker Awards - Joan Brugge and Mitch Dowsett  

 

 

SPP
2015 Accelerating Anticancer Agent Development and Validation Workshop H. Kim Lyerly, M.D. Duke University NC North Carolina Triangle to the Coast Affiliate SPP
Evidence Based Consensus Conference on Margins in DCIS Treated With and Without Radiotherapy Monica Morrow, M.D. Society of Surgical Oncology IL Chicagoland Area Affiliate SPP
AACR Programming - 2014-2015 --Prevention, Disparities, SABCS, Rally for Med Research, SPP, Awards, SITAs Michael Stewart American Association for Cancer Research (AACR) PA Philadelphia Affiliate SPP
2015 AACR Annual Meeting Michael Stewart American Association for Cancer Research (AACR) PA Philadelphia Affiliate SPP
24th Annual AACR Workshop Molecular Biology in Clinical Oncology, July 19-26, 2015 Michael Stewart American Association for Cancer Research (AACR) PA Philadelphia Affiliate SPP
SSO 2015 Annual Cancer Symposium - March 25-28, 2015 in Houston, TX and the SSO 2015 Susan G. Komen Breast Cancer Research Award Eileen Widmer Society of Surgical Oncology IL Chicagoland Area Affiliate SPP
Friends of Cancer Research: 2014 ClinicalCancer  Research Workshop - Nov mtg Jeff Allen Friends of Cancer Research DC

 

SPP
8th International Symposium on the Breast Heather Ortner Dr. Susan Love Research Foundation CA Los Angeles County Affiliate SPP
Advanced Breast Cancer Third International Consensus Conference (ABC3) Alberto Costa European School of Oncology Italy Susan G. Komen Italia SPP
Mammary Gland Biology (GRS) Finding Your Pathway: Breast Development and Breast Cancer Nancy Ryan Gray Gordon Research Conferences RI

 

SPP
14th St. Gallen internation Breast Cancer Conference: Primary Therapy in Early Breast Cancer, Vienna, Austria March 18-21, 2015 Hans-Joerg Senn St. Gallen Oncology Conferences Switzerland

 

SPP
Travel scholarship sponsorship; Obesity Week – November 2-7, 2015 – Los Angeles, CA Francesca Dea The Obesity Society MD

 

SPP
HGEI-Lancet Commission on Global Access to Pain Control and Palliative Care Felicia Knaul, Ph.D. Harvard Global Equity Initiative MA Massachusetts Affiliate SPP
AIS Program at 2015 ASCO Breast Cancer Symposium Elda Railey Research Advocacy Network TX North Texas Affiliate SPP
A2SPIRE Grant Kathryn Martinez Tyler Affiliate of Susan G. Komen TX Tyler Affiliate SPP
A2SPIRE Grant Kirsten Bruce Kansas Affiliate of Susan G. Komen KS Kansas Affiliate SPP
A2SPIRE Grant Carli Howard Greater Kansas City Affiliate of Susan G. Komen MO Greater Kansas City Affiliate SPP
A2SPIRE Grant Lisa Wolter Orange County Affiliate of Susan G. Komen CA Orange County Affiliate SPP
A2SPIRE Grant Kelly Kesler Maryland Affiliate of Susan G. Komen MD Maryland Affiliate SPP
A2SPIRE Grant Pam Kohl North Carolina Triangle to the Coast Affiliate of Susan G. Komen NC North Carolina Triangle to the Coast Affiliate SPP
IMPAKT Breast Cancer Conference, May 7-9, 2015 Keith McGregor European School of Medical Oncology Switzerland

 

SPP
Comparative Baseline Needs Assessment for Breast Cancer Awareness and Management in Middle East and North Africa Rola Shaheen King Hussein Cancer Foundation/Jordan Breast Cancer Program Jordan

 

Global
Pathways and Barriers for Breast Cancer Patients in Salvador:   An Assessment of the Breast Cancer Situation from Screening to Treatment  Lapa Monteiro, Maria Do Carmo Viva Maria Brazil

 

CAT
Barriers, Needs and Opportunities in the Breast Cancer Continuum of Care in Women Living in Rural Communities and Indigenous Communities Maria Roquebert Geinsa Gestoria Integral Panama

 

CAT
Creating a Navigation Pathway into the Ministry of Health's System in Monterrey Mireles Aguilar, Maria Teresa Medicos por el Cancer Mexico

 

CAT
Diagnosis of the quality, infrastructure and barriers related to Breast Cancer (BC) Care Programs in the Metropolitan Area of Guadalajara (MAG). CAT
Replicating Success: The Chicago Model to Reduce Racial Disparities in Breast Cancer Mortality Ann Marie Murphy, Ph.D. Metropolitan Chicago Breast Cancer Task IL Chicagoland Area Affiliate Community Health/Special Grant